Current Ratio in % of BriaCell Therapeutics Corp. from Q1 2023 to Q2 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
BriaCell Therapeutics Corp. quarterly Current Ratio history and change rate from Q1 2023 to Q2 2025.
  • BriaCell Therapeutics Corp. Current Ratio for the quarter ending 31 Jul 2025 was 270 %, a 31.9% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

BriaCell Therapeutics Corp. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q2 2025 270 +65.4 +31.9% 31 Jul 2025
Q1 2025 154 -309 -66.8% 30 Apr 2025
Q4 2024 101 -961 -90.5% 31 Jan 2025
Q3 2024 126 -2.09K -94.3% 31 Oct 2024
Q2 2024 205 -2.46K -92.3% 31 Jul 2024
Q1 2024 463 -3.17K -87.2% 30 Apr 2024
Q4 2023 1.06K 31 Jan 2024
Q3 2023 2.22K 31 Oct 2023
Q2 2023 2.66K 31 Jul 2023
Q1 2023 3.63K 30 Apr 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.